US · HNGE
Hinge Health, Inc.
- Sector
- Healthcare · Medical - Healthcare Information Services
- Headquarters
- San Francisco, CA 94105
- Website
- hingehealth.com
Price · as of 2025-12-31
$45.43
Market cap 3.37B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $47.39 | +4.31% |
| Intrinsic Value(DCF) | $306.26 | +574.14% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | $3.79 | $0.00 | |||
| 2025 | $44.86 | $47.39 | $677.92 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Hinge Health, Inc.'s (HNGE) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $47.39
- Current price
- $45.43
- AI upside
- +4.31%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$306.26
+574.14% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| HNGE | Hinge Health, Inc. | $45.43 | 3.37B | +4% | +574% | — | — | -6.72 | 9.38 | 6.04 | -5.91 | -0.20 | 11.39 | 79.65% | -92.94% | -89.86% | -132.86% | 6793.55% | -74.51% | 0.02 | — | 1.47 | 1.19 | 0.37 | 336000.00% | 5058.00% | 27749.00% | 4.81% | 0.47 | -2122.88% | 0.00% | 0.00% | 1.83% | -5.85 | 18.72 | 5.44 | 2.49 |
| AKRO | Akero Therapeutics, Inc. | $54.65 | 4.5B | — | — | — | — | -11.22 | 3.77 | — | -7.43 | -37.70 | 3.77 | 0.00% | — | — | -39.22% | -1042.60% | -35.85% | 0.05 | -61.14 | 19.38 | 18.69 | 1.06 | 2976.00% | — | 5898.00% | -8.17% | -5.79 | -844.19% | 0.00% | 0.00% | 3.41% | -7.43 | -9.18 | — | 20.91 |
| CRNX | Crinetics Pharmaceuticals… | $41.10 | 4.21B | +36% | -54% | — | — | -8.22 | 3.86 | 705.95 | -6.17 | -24.08 | 3.86 | 80.15% | -9534.48% | -8585.18% | -40.17% | -2936.77% | -36.34% | 0.05 | — | 12.32 | 12.09 | 0.11 | 3415.00% | 42166.00% | 6695.00% | -10.03% | -4.44 | -2180.46% | 0.00% | 0.00% | 0.00% | -5.51 | -7.42 | 525.26 | 14.87 |
| DYN | Dyne Therapeutics, Inc. | $15.62 | 2.57B | — | — | — | — | -3.68 | 1.85 | — | -1.74 | — | 1.85 | 0.00% | — | — | -88.03% | -9599.05% | -74.14% | 0.04 | — | 15.60 | 15.20 | 1.31 | -1468.00% | — | 5604.00% | -25.25% | -6.92 | -8227.36% | 0.00% | 0.00% | 27.18% | -1.60 | -1.86 | — | 8.91 |
| IMVT | Immunovant, Inc. | $27.73 | 5.64B | — | — | — | — | -6.14 | 3.59 | — | -4.18 | -13.59 | 3.59 | 0.00% | — | — | -62.46% | 3667.16% | -57.36% | 0.00 | — | 11.16 | 10.42 | 1.63 | 4521.00% | — | 7552.00% | -14.82% | -5.47 | 3152.27% | 0.00% | 0.00% | 3.09% | -4.17 | -4.85 | — | 19.16 |
| INDV | Indivior Pharmaceuticals … | $32.72 | 4.08B | +249% | +42% | -77% | -38% | 19.04 | -40.38 | 3.23 | 12.71 | 0.18 | -39.58 | 80.23% | 21.15% | 16.95% | -93.96% | -87.53% | 16.67% | -0.62 | 5.82 | 0.71 | 0.49 | -0.44 | 1083333.00% | 429.00% | -142857.00% | -2.33% | -0.03 | 35.36% | 0.00% | 0.00% | 5.03% | 14.75 | -41.54 | 3.12 | 3.05 |
| LNTH | Lantheus Holdings, Inc. | $74.91 | 5.09B | +40% | +25% | -60% | -60% | 22.05 | 4.73 | 3.34 | 14.36 | — | 40.39 | 61.10% | 20.16% | 15.15% | 21.45% | 30.32% | 11.10% | 0.00 | 15.74 | 2.70 | 2.15 | -1.07 | -2179.00% | 50.00% | -2820.00% | 6.88% | 1.17 | 46.40% | 0.00% | 0.00% | 1.26% | 15.41 | 13.53 | 3.11 | 4.60 |
| OSCR | Oscar Health, Inc. | $13.64 | 3.54B | +238% | +3,520% | — | — | -8.28 | 3.75 | 0.31 | -0.28 | — | 3.75 | 14.38% | -3.39% | -3.79% | -44.49% | 23.17% | -7.93% | 0.44 | -22.52 | 0.95 | 0.91 | 5.99 | -186594.00% | 2750.00% | 1138.00% | 28.86% | 0.23 | -61.87% | 0.00% | 0.00% | 30.44% | -0.27 | 0.10 | 0.01 | 1.28 |
| PRAX | Praxis Precision Medicine… | $336.75 | 7.12B | -61% | — | — | — | -24.53 | 8.47 | — | -22.57 | -76.60 | 8.47 | 0.00% | — | — | -45.83% | -195.82% | -42.68% | 0.00 | — | 10.22 | 10.03 | 1.18 | 3203.00% | -10000.00% | 8908.00% | -3.35% | -4.17 | -149.55% | 0.00% | 0.00% | 1.92% | -20.97 | -27.46 | — | 72.54 |
| VKTX | Viking Therapeutics, Inc. | $33.84 | 3.91B | — | — | — | — | -10.44 | 5.88 | — | -7.76 | -4.84 | 5.88 | 0.00% | — | — | -47.34% | 896.45% | -44.29% | 0.00 | -7023.96 | 9.33 | 9.21 | 0.42 | 21584.00% | — | 21745.00% | -7.42% | -3.64 | 635.14% | 0.00% | 0.00% | 3.73% | -7.76 | -10.95 | — | 27.00 |
| WGS | GeneDx Holdings Corp. | $79.71 | 2.3B | +102% | -61% | -91% | — | -94.92 | 6.47 | 4.67 | 298.22 | — | 15.81 | 69.74% | -2.76% | -4.92% | -7.60% | -4.61% | -4.25% | 0.49 | -4.65 | 2.46 | 2.26 | 7.09 | -6237.00% | 3997.00% | -14196.00% | 0.71% | 0.31 | 5.60% | 0.00% | 0.00% | 0.00% | -167.43 | 138.55 | 4.62 | 2.21 |
About Hinge Health, Inc.
Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.
- CEO
- Daniel A. Perez
- Employees
- 1.51K
- Beta
- 1.75
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($306.26 ÷ $45.43) − 1 = +574.14% (DCF, example).